Does apigenin help you sleep better?
There are only preliminary signals from observational and animal research; clinical evidence in humans is entirely absent. If you are considering apigenin for better sleep, be aware that no study confirms it works, and that absorption by the body is limited regardless.
Read the full answer
People who eat more apigenin through their diet sleep slightly better. That emerged from an observational study of nearly 2,000 Italian adults. But this is an association, not proof that apigenin causally improves sleep. Moreover, the association disappeared entirely in people who were overweight or obese.
In mouse research, the combination of apigenin with magnesium did show a clear effect: sleep duration increased by 32 to 44 percent, depending on the model. The combination worked better than either substance alone. Whether this also works in humans has not been studied. Mouse results do not translate to humans nearly as often as one might hope.
How apigenin might act on sleep has been studied in cells and mice. In cultured brain cells, it inhibits receptors that normally regulate arousal or sleep, with a net effect of reduced brain activity. In mice, a particular inflammatory substance in the brain simultaneously decreased. These are possible leads, but not proof that the same mechanism operates in humans.
A serious practical problem is that apigenin barely dissolves in water. As a result, the body absorbs it poorly. Researchers have developed a more soluble variant, but it is not available as a supplement. Ordinary apigenin supplements run into this problem.
Clinical research in humans is entirely lacking. There are no randomised studies that directly test apigenin supplementation and sleep in humans. Anyone considering taking apigenin as a sleep supplement is therefore buying a product without clinical evidence that it works.
Sources: one observational study in humans (n=1936, PMID 32357534), one mouse study with the combination apigenin+magnesium (PMID 41701207), one cell culture study on receptor activity (PMID 15464088), one pharmaceutical study on solubility (PMID 29923397), one narrative review without human intervention data (PMID 40418260). No RCTs in humans available.